Aug 2026· Brazilian Journal of Analytical Chemistry· 0 citations
TL;DR
This review discusses a coherent series of exosome biosensing platforms developed within the research group, contextualized with representative contributions from other teams in the field, highlighting the potential of these approaches for POC applications and resource-limited settings.
Abstract
Exosomes are nano-sized extracellular vesicles secreted by cells and they have emerged as promising biomarkers for non-invasive clinical diagnostics. However, their small size (30–200 nm) and low abundance in biofluids pose significant challenges for isolation and detection. This review highlights recent advances in electrochemical biosensors for exosome detection, with particular emphasis on immunomagnetic separation (IMS) strategies and electrochemical platforms developed for clinical diagnostics. Within this context, this review discusses a coherent series of exosome biosensing platforms developed within our research group, contextualized with representative contributions from other teams in the field. The reviewed platforms rely on immunological, enzymatic, and nucleic acid–based recognition strategies, and integrate selective exosome capture, typically assisted by magnetic separation, with electrochemical or related readouts for sensitive detection in complex biological matrices. These approaches integrate selective exosome capture, typically assisted by magnetic separation with electrochemical transduction, enabling sensitive detection in complex biological matrices. Methodologically, the platforms exploit different exosomal features, including surface-associated proteins, intrinsic enzymatic activity, and nucleic acid cargo, illustrating the versatility of electrochemical biosensing for exosome analysis. Reported limits of detection range from approximately 10⁵ down to 10² exosomes μL⁻¹, with demonstrated capability to discriminate clinically relevant samples (e.g., cancer versus healthy controls, Alzheimer’s disease versus controls). The integration of magnetic separation with electrochemical readout in portable formats supports sensitive, specific, and rapid analysis, highlighting the potential of these approaches for POC applications and resource-limited settings. In this regard, this article pays tribute to Prof. Kubota’s legacy in biosensing by reflecting his long-standing emphasis on transforming innovative analytical concepts into solutions suited for real diagnostic settings.
This review discusses current breakthroughs in aptamer and peptide functionalized microfluidic biosensors for exosome-based cancer diagnostics, focusing on their translation into POC applications, and highlights present challenges, as well as potential future prospects.
P. Priyanka, S. Hemalatha· Microfluidics and Nanofluidi...· 0 citations
This review consolidates current advances in exosome biology, including their biogenesis, isolation, characterization, and engineering for antimicrobial applications, and identifies EV-based systems may help address selected antimicrobial resistance (AMR) challenges by enabling delivery of antibiotics, antimicrobial pe...
Y. Choonara, K. Mnqiwu, M. Chougule et al.· International journal of pha...· 0 citations
Saliva-based diagnostics offer a compelling route toward accessible healthcare, particularly in low-resource settings where conventional laboratory infrastructure is limited. Extracellular vesicles (EVs) present in saliva carry molecular signatures reflective of physiological and pathological states, yet their clinical...
Ajitesh Dhal, Ana Elena Aviña, Cheng-Jen Chang et al.· In Analysis· 0 citations
Extracellular vesicles (EVs) are promising liquid-biopsy analytes for hepatocellular carcinoma (HCC) because they carry complementary biomarker information in both surface and luminal compartments and are accessible from multiple clinically relevant biofluids. In HCC, however, the diagnostic performance of EV assays is...
Ruikang Ming, Xue-Meng Gao, Xiao-Ying Hu et al.· ACS Sensors· 0 citations
This work highlights strategies specifically designed for epithelial-mesenchymal transition (EMT)-associated CTC phenotypes and explores AI- and IoT-enabled implementations for decentralized oncology, and a comprehensive evaluation of electrochemical approaches for CTC and ctDNA detection.
Tuğba Ören Varol, Mehmet Varol· Annals of Biomedical Enginee...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.